InventisBio Co., Limited (SHA:688382)
China
· Delayed Price · Currency is CNY 23.60
-0.12 (-0.51%)
At close: May 23, 2025, 2:57 PM CST
InventisBio Market Cap
InventisBio has a market cap or net worth of 18.37 billion as of June 5, 2025. Its market cap has increased by 226.35% in one year.
Market Cap
18.37B
Enterprise Value
16.76B
Revenue
168.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.60
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 18.37B, an increase of 108.92%. That is a compound annual growth rate of 29.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 17.81B | 132.21% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 362.72B |
| Shenzhen Mindray Bio-Medical Electronics | 273.17B |
| WuXi AppTec | 181.57B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.11B |
| Sichuan Biokin Pharmaceutical | 120.77B |
| Aier Eye Hospital Group | 115.34B |
| Shanghai United Imaging Healthcare | 112.70B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |